Aberdeen Group plc Increases Position in Danaher Corporation $DHR

Key Points

• Aberdeen Group plc increased its stake in Danaher Corporation by 2.0%, holding approximately 1.1 million shares valued at $223.66 million.
• Several institutional investors, including Vanguard Group and Bank of New York Mellon, also increased their holdings in Danaher, indicating a strong interest from hedge funds and institutional investors who own over 79% of the company's stock.
• Danaher reported better-than-expected earnings of $1.80 EPS for the last quarter, surpassing analysts' estimates and showing a revenue increase of 3.4% year-over-year.

Aberdeen Group plc grew its stake in Danaher Corporation (NYSE:DHR - Free Report) by 2.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,106,773 shares of the conglomerate's stock after acquiring an additional 21,482 shares during the period. Aberdeen Group plc owned 0.15% of Danaher worth $223,662,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of DHR. Fayez Sarofim & Co raised its holdings in Danaher by 0.6% during the fourth quarter. Fayez Sarofim & Co now owns 8,287 shares of the conglomerate's stock valued at $1,902,000 after acquiring an additional 50 shares during the period. Coastal Bridge Advisors LLC grew its position in shares of Danaher by 4.8% during the fourth quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate's stock worth $252,000 after purchasing an additional 50 shares in the last quarter. MGO One Seven LLC raised its stake in Danaher by 1.3% during the 4th quarter. MGO One Seven LLC now owns 4,285 shares of the conglomerate's stock valued at $984,000 after purchasing an additional 53 shares during the period. Hills Bank & Trust Co lifted its holdings in Danaher by 0.3% in the 1st quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate's stock worth $3,693,000 after purchasing an additional 53 shares in the last quarter. Finally, Sageworth Trust Co boosted its stake in Danaher by 2.3% in the 1st quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate's stock worth $493,000 after purchasing an additional 54 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on DHR. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Argus decreased their price target on shares of Danaher from $260.00 to $240.00 in a research note on Wednesday, April 23rd. Wells Fargo & Company cut their price objective on Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 23rd. Robert W. Baird lifted their target price on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. Finally, HSBC dropped their price target on Danaher from $270.00 to $240.00 in a research note on Friday, April 25th. Seventeen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $247.61.

Danaher Trading Down 0.4%

NYSE DHR traded down $0.9530 on Wednesday, hitting $211.2470. 3,302,498 shares of the stock were exchanged, compared to its average volume of 4,344,760. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The stock has a fifty day moving average price of $200.46 and a two-hundred day moving average price of $199.62. The firm has a market capitalization of $151.26 billion, a P/E ratio of 44.95, a P/E/G ratio of 2.96 and a beta of 0.73. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business's revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.